Clinical trial
Uterine Leiomyoma Treatment With Radiofrequency Ablation
NCT01840124 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Uterine Leiomyoma Treatment With Radiofrequency Ablation
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- January 31, 2020
- Enrollment
- 26 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
uterine fibroids